021P London, UK
8th European Workshop on Cannabinoid Research

 

 

Identification of medium chain N-acyl glycines as GPR132 (G2A) receptor agonists

J. Foster1, J. Harvey1, A. J. Irving2, A. J. Brown31University of Dundee, Dundee, United Kingdom, 2University College Dublin, Dublin, United Kingdom, 3Glaxo Smith Kline, Stevenage, United Kingdom.

Introduction: The N-acyl amides are a family of endogenous signalling lipid molecules typically consisting of an acyl chain conjugated to a biological amine (which may be dopamine, an amino acid, etc). The prototypical member of this family, N-arachidonoyl ethanolamine, exerts biological activity through the cannabinoid receptors [1]. We show that the activity of this family of molecule extends to the orphan GPR132 (G2A) receptor, by demonstrating agonist activity of medium chain N-acyl glycines.

Method: Rat Basophilic Leukemia (RBL) cells stably expressing human G2A(a) were loaded with Fura-2 AM and microfluorimetry experiments performed to measure agonist-induced calcium mobilisation. Data was analysed using unpaired students T-test to compare RBL-G2A with RBL parental. For yeast experiments, human, rat, mouse, and zebrafish G2A receptors were stably integrated into modified yeast strains containing yeast-human G-protein chimeras. Enzyme mediated hydrolysis of fluorescein di-β-D-glucopyranoside was used to measure agonist-dependent yeast growth [2]. The DiscoverX PathHunter assay was used to measure agonist-induced βarrestin-2 association with human and mouse G2A.

Result: In the calcium microflourimetry experiments N-linoleoyl glycine (NLG) had equal agonist potency as the reported G2A endogenous agonist 9-hydroxyoctadecadienoic acid (9-HODE) (Figure 1) [3]. In yeast and βarrestin-2 association assays all G2A species orthologues tested were sensitive to medium chain N acyl-glycines (Table 1 and 2). N-palmitoyl glycine had higher potency than 9-HODE in the yeast assay, whereas 9-HODE was more potent than any medium chain N-acyl glycine tested in the βarrestin-2 association assay. Finally, we used a G2A antagonist to demonstrate inhibition of G2A agonism by N-acyl glycines on human G2A(a) (Figure 2).

Conclusion: We identify medium chain N-acyl glycines as agonists of the G2A receptor.

[1] Devane, W. A. et al. (1992). Science, 258(5090), 1946-1949.

[2] Dowell, S. J., & Brown, A. J. (2009). Methods Mol Biol, 552, 213-229. doi:10.1007/978-1-60327-317-6_15

[3] Obinata, H. et al. (2005). J Biol Chem, 280(49), 40676-40683. doi:10.1074/jbc.M507787200